Since PPX is required for Mtb persistence in necrotic lung lesions, it is possible that a small molecule inhibitor to this enzyme may target “persister” bacilli, thereby contributing to shortening of TB treatment. The gene discussed is PPP4C; the disease is tuberculosis.